Linkedin-in Facebook-f X-twitter
Image credit - a-c-EUGCtKKCWbE-unsplash
Facebook
LinkedIn
X

Glasgow biotech Mironid raises £34m Series B to push kidney disease candidate into the clinic

Glasgow-based biopharmaceutical company Mironid has raised £34 million in a Series B funding round, with the Scottish National Investment Bank

Glasgow biotech Mironid raises £34m Series B to push kidney disease candidate into the clinic...
Edinburgh-founded Wordsmith adds $14m to Series B as Intact Private Capital leads extension...
CRO redefined: how RoukenBio went from Scottish biotech start-up to global immunology pioneer...

Other articles from Silicon Scotland

Scottish August 14, 2026 News